Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma - Dimopoulos, Meletios A.; Dytfeld, Dominik; Grosicki, Sebastian; Moreau, Philippe; Takezako, Naoki; Hori, Mitsuo; Leleu, Xavier; Leblanc, Richard; Suzuki, Kenshi; Raab, Marc-Steffen (The New England journal of medicine, 2018)
Gesehen am 13.03.2020